20 Years - In Lung Cancer Diagnosis and Care

|

article image
Early diagnosis of lung cancer is linked to achieving better outcomes for patients, and improving rate of survival1 Over the last twenty years significant technological advances, developments in research and evolutions in specialized care have had a significant improvement to both the diagnosis of lung cancer and lung cancer supportive care.

Spotlight

Celon Laboratories Limited

Celon Labs is a leader in the development and marketing of specialty products which serve niche therapy areas. Using in-house research & development capabilities, operational flexibility, manufacturing and regulatory expertise, Celon has taken a wide variety of products from laboratory to the market.

OTHER ARTICLES

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 11, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 11, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | March 11, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

Spotlight

Celon Laboratories Limited

Celon Labs is a leader in the development and marketing of specialty products which serve niche therapy areas. Using in-house research & development capabilities, operational flexibility, manufacturing and regulatory expertise, Celon has taken a wide variety of products from laboratory to the market.

Events